Marta Moreira
About
Marta Moreira is a scholar working on Epidemiology, Microbiology and Surgery.
According to data from OpenAlex, Marta Moreira has authored 29 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 19 papers in Microbiology and 3 papers in Surgery. Recurrent topics in Marta Moreira's work include Pneumonia and Respiratory Infections (23 papers), Bacterial Infections and Vaccines (19 papers) and Respiratory viral infections research (18 papers). Marta Moreira is often cited by papers focused on Pneumonia and Respiratory Infections (23 papers), Bacterial Infections and Vaccines (19 papers) and Respiratory viral infections research (18 papers). Marta Moreira collaborates with scholars based in Belgium, Finland and United Kingdom. Marta Moreira's co-authors include Lode Schuerman, Dorota Borys, Taneli Puumalainen, Arto A. Palmu, Heta Nieminen, Terhi Kilpi, Esa Ruokokoski, Patricia Lommel, Jukka Jokinen and Marjan Hezareh and has published in prestigious journals such as The Lancet, The Lancet Infectious Diseases and BMC Public Health.
In The Last Decade
Marta Moreira
27 papers receiving 715 citations
Peers
Marta Moreira
D. A. Kafetzis Greece
Jolanta Bernatoniene United Kingdom
Carolina Soley Costa Rica
BRIAN M. GREENWOOD Gambia
K. Green Canada
Haruka Hishiki Japan
Jacqueline Sánchez United States
Abdoulie Bojang Gambia
Lotta Siira Finland
Citations per year, relative to Marta Moreira Marta Moreira (= 1×)
peers
D. A. Kafetzis
Countries citing papers authored by Marta Moreira
Since
Specialization
Citations
This map shows the geographic impact of Marta Moreira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Moreira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Moreira more than expected).
Fields of papers citing papers by Marta Moreira
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Marta Moreira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Moreira. The network helps show where Marta Moreira may publish in the future.
Co-authorship network of co-authors of Marta Moreira
This figure shows the co-authorship network connecting the top 25 collaborators of Marta Moreira. A scholar is included among the top collaborators of Marta Moreira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Moreira. Marta Moreira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Moreira, Marta, et al.. (2023). Development and Validation of ColonCAD – an artificial intelligence platform for the automatic segmentation, detection and classification of colon polyps. Endoscopy. 55(S 02). S255–S255.
2.
Nunes, Marta C., Marta Moreira, Anthonet Koen, et al.. (2020). Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials. Expert Review of Vaccines. 19(12). 1177–1189.
3.
Madhi, Shabir A., Marta Moreira, Anthonet Koen, et al.. (2020). Impact of HIV status and vaccination schedule on bacterial nasopharyngeal carriage following infant immunisation with the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in South Africa. Vaccine. 38(10). 2350–2360.
4.
Nieminen, Heta, Hanna Rinta‐Kokko, Janne J. Jokinen, et al.. (2019). Effectiveness of the 10-valent pneumococcal conjugate vaccine among girls, boys, preterm and low-birth-weight infants – Results from a randomized, double-blind vaccine trial. Vaccine. 37(28). 3715–3721.
5.
Kilpi, Terhi, Janne J. Jokinen, Taneli Puumalainen, et al.. (2018). Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial. Vaccine. 36(39). 5891–5901.
6.
Palmu, Arto A., Jukka Jokinen, Heta Nieminen, et al.. (2018). Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial. Vaccine. 36(14). 1816–1822.
7.
Madhi, Shabir A., Anthonet Koen, Lisa Jose, et al.. (2017). Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status. Medicine. 96(2). e5881–e5881.
8.
Vesikari, Timo, Aino Forstén, Tarja Kaijalainen, et al.. (2016). Effectiveness of the 10-Valent Pneumococcal NontypeableHaemophilus influenzaeProtein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland. Journal of the Pediatric Infectious Diseases Society. 5(3). 237–248.
9.
Moreira, Marta, Otávio Cintra, Julie Harriague, William P. Hausdorff, & Bernard Hoet. (2016). Impact of the introduction of the pneumococcal conjugate vaccine in the Brazilian routine childhood national immunization program. Vaccine. 34(25). 2766–2778.
10.
Palmu, Arto A., Janne J. Jokinen, Heta Nieminen, et al.. (2014). Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari).
11.
Palmu, Arto A., Janne J. Jokinen, Heta Nieminen, et al.. (2014). Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial. The Lancet Respiratory Medicine. 2(9). 717–727.
12.
Palmu, Arto A., Jukka Jokinen, Heta Nieminen, et al.. (2013). Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3–4 trial. The Lancet Infectious Diseases. 14(3). 205–212.
13.
Ruiz‐Palacios, Guillermo M., Li‐Min Huang, Tzou‐Yien Lin, et al.. (2012). Immunogenicity and Safety of a Booster Dose of the 10-valent Pneumococcal Haemophilus Influenzae Protein D Conjugate Vaccine Coadministered With the Tetravalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine in Toddlers. The Pediatric Infectious Disease Journal. 32(1). 62–71.
14.
Lin, Tzou‐Yien, Chun‐Yi Lu, Luan‐Yin Chang, et al.. (2012). Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan. Journal of the Formosan Medical Association. 111(9). 495–503.
15.
Palmu, Arto A., Jukka Jokinen, Dorota Borys, et al.. (2012). Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial. The Lancet. 381(9862). 214–222.
16.
Lalwani, Sanjay, Sukanta Chatterjee, Jugesh Chhatwal, et al.. (2012). Immunogenicity, safety and reactogenicity of the 10-valent pneumococcal non-typeableHaemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) when co-administered with the DTPw-HBV/Hib vaccine in Indian infants: a single-blind, randomized, controlled study. Human Vaccines & Immunotherapeutics. 8(5). 612–622.
17.
Kim, Chang Hwi, Jung Soo Kim, Sung Ho, et al.. (2011). Response to Primary and Booster Vaccination With 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Korean Infants. The Pediatric Infectious Disease Journal. 30(12). e235–e243.
18.
Ruiz‐Palacios, Guillermo M., et al.. (2011). Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeableHaemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) in Mexican infants. Human Vaccines. 7(11). 1137–1145.
19.
Dicko, Alassane, Olumuyiwa O. Odusanya, Santara Gaoussou, et al.. (2011). Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial. BMC Public Health. 11(1). 882–882.
20.
Moreira, Marta, et al.. (1997). Effects of policosanol on primary hypercholesterolemia: a 3-year open-extension follow-up. Current Therapeutic Research. 58(11). 868–875.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by D. A. Kafetzis Breakdown of academic impact, for papers by Jolanta Bernatoniene Breakdown of academic impact, for papers by Carolina Soley Breakdown of academic impact, for papers by BRIAN M. GREENWOOD Breakdown of academic impact, for papers by K. Green Breakdown of academic impact, for papers by Haruka Hishiki Breakdown of academic impact, for papers by Jacqueline Sánchez Breakdown of academic impact, for papers by Abdoulie Bojang Breakdown of academic impact, for papers by Lotta Siira